Literature DB >> 8249905

The evaluation of a portable clinical analyzer in the emergency department.

J Woo1, J B McCabe, D Chauncey, T Schug, J B Henry.   

Abstract

A recently available portable clinical analyzer (PCA), which examines sodium, potassium, chloride, glucose, urea nitrogen, and hematocrit levels on 60 microL of blood and calculates hemoglobin and osmolality levels within 2 minutes, was evaluated. Blood from 574 patients was drawn by emergency department staff, who immediately tested the samples with the PCA and transported them for plasma analysis on a reference analyzer in the clinical laboratory. Correlations between the PCA and the reference analyzer were as follows: R2 = 0.987 for urea nitrogen; R2 = 0.97, glucose; R2 = 0.937, K;R2 = 0.79, hematocrit; R2 = 0.751, sodium; and R2 = 0.689 for chloride. With its rapid turnaround, small sample requirement, and ease of operation, the PCA is most useful in an emergency department setting, where immediate access to clinically relevant laboratory testing is required in support of urgent clinical decision-making.

Entities:  

Mesh:

Year:  1993        PMID: 8249905     DOI: 10.1093/ajcp/100.6.599

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Point of care testing: randomised controlled trial of clinical outcome.

Authors:  J Kendall; B Reeves; M Clancy
Journal:  BMJ       Date:  1998-04-04

Review 2.  Diagnostic point-of-care tests in resource-limited settings.

Authors:  Paul K Drain; Emily P Hyle; Farzad Noubary; Kenneth A Freedberg; Douglas Wilson; William R Bishai; William Rodriguez; Ingrid V Bassett
Journal:  Lancet Infect Dis       Date:  2013-12-10       Impact factor: 25.071

3.  Point-of-care testing in Paediatric settings in the UK and Ireland: a cross-sectional study.

Authors:  Meenu Pandey; Mark D Lyttle; Katrina Cathie; Alasdair Munro; Thomas Waterfield; Damian Roland
Journal:  BMC Emerg Med       Date:  2022-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.